Combined immunodeficiency associated with increased apoptosis of lymphocytes and radiosensitivity fibroblasts.
Jane Peake, Penelope A. Jeggo(University of Sussex), Alain Fischer(Inserm), A Waugh, Emily Capulas, Belinda K. Singleton(National Health Service), Frédéric Rieux‐Laucat(Inserm), Jean‐Pierre de Villartay(Université Paris Cité), E.P. Malaise, Françoise Le Deist(Centre National de la Recherche Scientifique), A. Priestley(Brighton and Sussex Medical School), Claire Hivroz(Inserm), AJ Cant, Nicolas Foray(Inserm)
PubMed
July 15, 1999
Cited by 15
Related Papers
<i>LMO2</i> -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1
|Science|2003|3.5k
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
|Science|2020|3.2k
Gene Therapy of Human Severe Combined Immunodeficiency (SCID)-X1 Disease
|Science|2000|2.6k
A Serious Adverse Event after Successful Gene Therapy for X-Linked Severe Combined Immunodeficiency
|New England Journal of Medicine|2003|1.8k
Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1
|Journal of Clinical Investigation|2008|1.8k